Sell Research In Motion Ltd. (BBRY) Ahead of Earnings

Page 1 of 2

Shares of beleaguered smartphone giant Research In Motion Ltd (NASDAQ:BBRY) have sunk lower after the having reached a 52-week high of $18.32 on Jan. 24. The stock is down more than 20% over the past two months. However, shares are still up 140% since reaching bottom at $6.22 last September. Investors are wondering what’s next. But that’s where things get complicated.

“Pretty good” is not as good as “Wow!”
Research In Motion Ltd faced an uphill battle. The company needed to remove the negative stigma that’s been associated with its name. The company, formerly known as Research In Motion Ltd (NASDAQ:BBRY), had become the “new Palm,” the once-dominant smartphone manufacturer that was killed off by Research In Motion Ltd.

Today, however, it is Research In Motion Ltd that’s suffering the same morbid fate as Palm. This time, it’s at the hands of Apple Inc. (NASDAQ:AAPL) and Samsung. Remarkably, even Microsoft Corporation (NASDAQ:MSFT)‘s Windows Phone has surpassed BlackBerry. However, BlackBerry had an ace called BB10, the new platform that was going to revolutionize the company. Investors bought into the idea. After numerous product delays, on Jan. 30, the company finally unveiled the phone. Unfortunately, the bar was set too high. The reception was underwhelming. The Street expected “Wow!” The company, however, delivered “pretty good.”

This was unacceptable, especially for Research In Motion Ltd (NASDAQ:BBRY), which had the impossible task of coming back from the dead. The launch fell short of the “Lazarus” quality that the Street expected. The phone, while pretty good, offered no new mobile experience. And the stock got punished for it — falling as much as 25% the following day.

Who are we kidding here?
Current BlackBerry users were impressed. But that’s not saying much. Research In Motion Ltd (NASDAQ:BBRY) did not present anything that would cause a non-BlackBerry user to switch from Apple or Samsung. This point was very evident last week when the phones when on sale in the U.S. for the first time. The so-called “buzz,” long lines, tents, overnight sleeping bags — things that have become standard with product launches from Apple and Samsung — were nowhere to be seen for BlackBerry.

Granted, this is not a predictor of success. And BlackBerry enthusiasts will argue that this “buzz” is not needed. I don’t buy it. Neither does the Street. The company has sold investors on the idea that the new phones and platform can revive its fight against Apple and Google. But investors yawned. Research In Motion Ltd (NASDAQ:BBRY) bulls are now suggesting that whether or not the company is able to steal market share from Apple or Samsung does not matter. Then what’s the point, especially after the company has waged its entire future on BB10?

Research In Motion (BBRY)

Research In Motion Ltd (NASDAQ:BBRY) can’t survive solely on the support of its existing users. The company’s ability to attract new customers away from competing devices is how Research In Motion Ltd will be judged. And the Street doesn’t feel confident that the new phonecan do that, which explains the 17% sell-off last week once the device finally hit the stores. Unfortunately, the sell-off may not be over.

A new name, new era — what to expect?
The company begins a new era under its new name and ticker when Research In Motion Ltd announces its fiscal fourth-quarter earnings results this Thursday for the period ending March 2. No one knows what to expect.

Estimates are all over the map. The Street has had a hard time pinning down sales figures for BlackBerry’s Z10 phones, which launched globally earlier in the quarter. For instance, Wells Fargo & Co (NYSE:WFC) expects the company to report a loss of $0.23 per share on revenue of $2.99 billion. Raymond James Financial, Inc. (NYSE:RJF) sees a loss of $0.17 on $3 billion in revenue.

As far as devices sales are concerned for the Z10, the figures range from 500,000 units from Sterne Agee to 1 million projected by BMO Capital. There is no real consensus. This may or may not matter, however. The company is coming off a decent third quarter — reporting a net loss of $0.22 per share on revenue of $2.7 billion, which beat on both top and bottom line estimates.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!